Summit Therapeutics Inc.

Equities

SMMT

US86627T1088

Market Closed - Nasdaq Other stock markets 21:00:00 16/01/2026 GMT			5-day change	1st Jan Change
17.04 ^USD	-1.33%		-13.41%	-2.57%

01-13	AbbVie Enters Cancer Treatment Space via RemeGen Licensing Deal, UBS Says	MT
01-12	Summit Therapeutics Inc. Announces Submission of Biologics License Application to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC	CI

Transcript : Summit Therapeutics Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 03

Published on 11/18/2025 at 04:35 pm GMT - Modified on 11/18/2025 at 05:35 pm GMT

S&P Capital IQ

Presenter Speech
Yuxi Dong (Analysts)

All right. Good afternoon. Thanks, everybody, for joining Jefferies Healthcare Conference in London. My name is Clara Dong. I'm one of the biotech analysts here at

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Summit Therapeutics Inc.

01-13	AbbVie Enters Cancer Treatment Space via RemeGen Licensing Deal, UBS Says	MT
01-12	Summit Therapeutics Inc. Announces Submission of Biologics License Application to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC	CI
01-12	Summit Therapeutics Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:45 AM
01-12	Summit Therapeutics, GSK Team up on Clinical Trial for Combination Cancer Therapy	MT
01-12	Summit Therapeutics Files Marketing Application for Lung Cancer Therapy	MT
01-12	Summit Therapeutics Announces Clinical Trial Collaboration with GSK plc to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate	CI
12-17	Barclays Upgrades Summit Therapeutics to Equal Weight From Underweight, Adjusts Price Target to $18 From $16	MT
12-09	Akeso, Inc. Announces Significant Improvement in Quality of Life Reported in Updated HARMONi-6 Data for Ivonescimab at ESMO Asia	CI
12-03	Summit Therapeutics Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 02:10 PM
12-02	Summit Therapeutics Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 10:30 AM
11-18	Summit Therapeutics Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 03:30 PM
11-10	Summit Therapeutics Inc. Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 03:30 PM
11-07	Akeso Announces Final OS Analysis Results Of Ivonescimab HARMONi-A Study At SITC 2025	CI
11-07	Summit Therapeutics Says Ivonescimab, Chemotherapy Combination Shows Benefit in Treating Lung Cancer	MT
24/10/25	Summit Therapeutics Insider Bought Shares Worth $9,999,983, According to a Recent SEC Filing	MT
22/10/25	Summit Therapeutics Raises $500 Million Via Private Placement	MT
22/10/25	Summit Therapeutics raises $500 million in private placement	RE
21/10/25	The Calm Before the Quarterly Storm
21/10/25	Analyst recommendations: Apple, Rivian, Goldman Sachs, Lyft, Morgan Stanley…
20/10/25	Summit Therapeutics Inc. announced that it expects to receive $500.036534 million in funding	CI
20/10/25	Summit Therapeutics Inc., Q3 2025 Earnings Call, Oct 20, 2025
20/10/25	Sector Update: Health Care Stocks Advance Pre-Bell Monday	MT
20/10/25	Sector Update: Health Care	MT
20/10/25	Summit Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
20/10/25	Stocks Rise Pre-Bell as Traders Await Earnings, Key Inflation Data; AWS-Linked Internet Outage Impacts Major Websites	MT